You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 201331 - 201340 of 207728 results
  1. Discovering a Novel Immunophilin to Lower the Toxicity of Cancer Therapeutics

    SBC: Amplyx Pharmaceuticals, Inc.            Topic: NCATS

    DESCRIPTION (provided by applicant): Chemotherapy induced peripheral neuropathy (CIPN) is a frequent and often dose limiting side effect of mainstay chemotherapeutics including taxanes, bortezomib, vinca alkaloids, platinum complexes, and newly approved therapeutics such as Eribulin. Initial symptoms of CIPN include sensory loss and pain in the extremities, and can later progress to uncontrolled ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  2. Interactive Multimedia Intervention to Improve Colonoscopy and Bowel Prep Adhere

    SBC: QURVE LEARNING LLC            Topic: NCATS

    DESCRIPTION (provided by applicant): Mortality from colorectal cancer (CRC) can be reduced through screening programs. Regardless of the primary strategy (fecal occult blood testing, sigmoidoscopy, colonoscopy, fecal DNA, computed tomographic colonography[virtual colonoscopy]) colonoscopy is required to evaluate positive screening tests and to detect or remove colonic neoplasia. Colonoscopy qualit ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  3. Combination chemo-siRNA gene therapy of nonmuscle-invading bladder cancer

    SBC: OPTIMUM THERAPEUTICS, LLC            Topic: NCATS

    DESCRIPTION (provided by applicant): Bladder cancer is the fourth most common cancer in the US. At presentation, gt80% of bladder tumors are organ-confined, separated clinically into two groups. The most common group is the nonmuscle-invading tumors, accounting for about 70-80% of cases. This group is managed by surgery, plus neo- or adjuvant intravesical immunotherapy or chemotherapy. Intravesic ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  4. Innovative Web-Based Intervention for Smoking Cessation among College Students

    SBC: MARKETZERO, LLC            Topic: NCATS

    DESCRIPTION (provided by applicant): Tobacco use is the leading cause of cancer death. While daily tobacco consumption in the United States has declined to 18.1%,1, 2 nondaily smoking (smoking on some days but not every day) is increasing,3 particularly among young adults.2 Yet, nondaily smokers are typically excluded from cessation trials.4 Because smokers who quit by 30 have cancer death risk si ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  5. iDecide: A Mobile Decision Support Tool Used for Adjuvant Therapy

    SBC: EYES OF THE WORLD MEDIA GROUP, INC.            Topic: NCATS

    DESCRIPTION (provided by applicant): Breast cancer remains a leading cause of cancer deaths among women worldwide. Recurrence of cancer is 10-20% within 10 years after surgery and up to 60% or higher in patients with more aggressive cancers. Determining the best adjuvant therapy for an individual is daunting, complex, and often overwhelming, yet is of primary importance for shared decision making ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  6. A Data-mining Approach to CAM Medication Reconciliation

    SBC: Transcendent International, LLC            Topic: NCATS

    DESCRIPTION (provided by applicant): Due to its complex, multi-herb nature, many patients who use Complementary and Alternative Medicine (CAM) do not have full knowledge of the ingredients included in their remedies. Lack of disclosure about CAM can placepatients at risk, as some herbal products can have adverse interactions with pharmaceuticals or cause harmful side effects. This proposal seeks t ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  7. A Personalized Messaging System for Cancer Screening

    SBC: RINGFUL LLC            Topic: NCATS

    DESCRIPTION (provided by applicant): Adherence with prostate cancer screening (such as PSA tests, and physician follow-ups), is less than perfect. In large part, this is because members of at-risk populations need to keep track of which tests are requiredand at what time. As screening guidelines and timetables become more personalized (e.g. different recommendations for follow-up intervals dependi ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  8. Rapid, low-cost mRNA analysis system for cancer companion diagnostics

    SBC: LiquiLume Diagnostics, Inc.            Topic: NCATS

    DESCRIPTION (provided by applicant): Nucleic acid tests comprise a large and growing segment of emerging molecular diagnostics ( MDx ). Companion diagnostics is an extremely important aspect of MDx due its potential to inform and accompany treatment of diseases using a genome-based, personalized approach. Taking the next step in molecular diagnostics will require the development of sensitive and ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  9. Suicide Safety Net: Multimedia Tools for Reliable Risk Management Documentation

    SBC: BEHAVIORAL TECH RESEARCH, INC.            Topic: NCATS

    DESCRIPTION (provided by applicant): Suicide is the 11th leading cause of death in the United States, accounting for approximately 34,000 deaths per year [1]. Despite the prevalence, many clinical research trials routinely exclude suicidal individuals dueto the lack of appropriate tools and protocols to adequately manage suicide risk. Similarly, clinicians are hesitant to treat suicidal patients, ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  10. Web-Based Simulated Patient Interviewing for Developing MI Skills for Health Care

    SBC: TALARIA, INC.            Topic: NCATS

    DESCRIPTION (provided by applicant): Modifiable behavioral risk factors for diabetes and cardiovascular disease, two of the most costly diseases in both human and monetary terms, include obesity, lack of physical activity, smoking tobacco and excess alcohol consumption. Despite a longstanding movement in the medical community towards models of chronic care to support changes in behavioral risk fac ...

    SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government